CD154+ graft antigen-specific CD4+ T cells are sufficient for chronic rejection of minor antigen incompatible heart grafts

American Journal of Transplantation

Volumn 6, Issue 6, 2006, Pages 1312-1319

  Huddleston, S J ^a   Hays, W S ^a   Filatenkov, A ^a   Ingulli, E ^a   Jenkins, M K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Effector mechanisms; Graft arteriosclerosis; Graft infiltrating lymphocytes; Heart lung transplantation; Minor histocompatibility antigens; T cell graft infiltration

Indexed keywords

CD11B ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; GLYCOPROTEIN P 15095; MINOR HISTOCOMPATIBILITY ANTIGEN; OVALBUMIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTIGEN SPECIFICITY; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CORONARY ARTERY; HISTOINCOMPATIBILITY; IMMUNOPATHOGENESIS; KNOCKOUT MOUSE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; TUNICA INTIMA;

EID: 33745823178     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01309.x     Document Type: Article

References (37)

1. Libby P, Pober J. Chronic rejection. Immunity 2001; 14: 387-397.
2. Rickenbacher PR, Pinto FJ, Chenzbraun A et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995; 25: 171-177.
3. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004; 23: 796-803.
4. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11: S38-44.
5. Shi C, Lee WS, He Q et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996; 93: 4051-4056.
6. Szeto WY, Krasinskas AM, Kreisel D, Krupnick AS, Popma SH, Rosengard BR. Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy. Transplantation 2002; 73: 1116-1122.
7. Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155-1161.
8. Chen Y, Demir Y, Valujskikh A, Heeger PS. Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol 2004; 164: 1407-1415.
9. Ensminger SM, Spriewald BM, Witzke O et al. Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation 2002; 73(2): 279-86.
10. Schnickel GT, Whiting D, Hsieh GR et al. CD8 lymphocytes are sufficient for the development of chronic rejection. Transplantation 2004; 78: 1634-1639.
11. Fischbein MP, Yun J, Laks H et al. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation 2001; 71: 1146-1153.
12. Sun H, Woodward JE, Subbotin VM et al. Use of recombinase activation gene-2 deficient mice to ascertain the role of cellular and humoral immune responses in the development of chronic rejection. J Heart Lung Transplant 2002; 21: 738-750.
13. Tanaka M, Zwierzchoniewska M, Mokhtari GK et al. Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant 2005; 5: 1286-1296.
14. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80-82.
15. Jones ND, Van Maurik A, Hara M et al. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol 2000; 165: 1111-1118.
16. Fischbein MP, Ardehali A, Yun J et al. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 2000; 165: 7316-7322.
17. Wang CY, Mazer SP, Minamoto K et al. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation 2002; 105: 1609-1614.
18. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
19. Guillot C, Guillonneau C, Mathieu P et al. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40lg results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 2002; 168: 1600-1609.
20. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000; 165: 3506-3518.
21. Ehst BD, Ingulli E, Jenkins MK. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 2003; 3: 1355-1362.
22. Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998; 76: 34-40.
23. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343-350.
24. Reinhardt R, Bullard D, Weaver C, Jenkins M. Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med 2003; 197: 751-762.
25. Grusby MJ, Auchincloss H, Jr., Lee R et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A 1993; 90: 3913-3917.
26. Pieraggi M, Nejjar I, Julian M, Bouissou H. Staining of elastic tissue by Verhoeff's iron hematoxylin. Ann Pathol 1986; 6: 74-77.
27. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
28. Ensminger SM, Witzke O, Spriewald BM et al. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation 2000; 69: 2609-2612.
29. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378: 617-620.
30. Maxwell JR, Campbell JD, Kim CH, Vella AT. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol 1999; 162: 2024-2034.
31. Fischbein MP, Yun J, Laks H et al. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2002; 123: 803-809.
32. Raisky O, Spriewald BM, Morrison KJ et al. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant 2003; 22: 177-183.
33. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998; 281: 96-99.
34. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993; 177: 925-935.
35. Jenkins MK, Taylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991; 147: 2461-2466.
36. Richards DM, Dalheimer SL, Ehst BD et al. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. J Immunol 2004; 172: 3469-3479.
37. Noda S, Aguirre SA, Bitmansour A et al. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 2006; 107: 30-38.